Case Study: Large Biopharmaceutical Company achieves faster rare disease diagnosis and launch readiness with Veeva Systems

Data and Platform Needs to Prepare for a Rare Disease Launch

Large Biopharmaceutical Company, an emerging biopharmaceutical firm preparing for its first rare disease launch, faced difficulty finding patients in a misdiagnosed condition and lacked full visibility into the complex patient journey and specialty referral patterns. To address this, it worked with Veeva Systems using Veeva Compass Patient Data to analyze longitudinal records, specialists, and diagnoses across the care pathway.

Veeva Systems helped the company identify key disease markers, uncover important comorbidities, and segment the healthcare providers most likely to see high-risk patients, especially relevant specialists such as urologists and nephrologists. The analysis improved HCP targeting, clarified referral and treatment patterns, and supported earlier intervention and diagnosis, while also helping the brand define launch KPIs and build a stronger foundation for its commercial launch.